What's in Sinew Pharma Inc.'s pipeline?

Sinew Pharma Inc. has 8 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 3 in Phase 1.

Which companies overlap with Sinew Pharma Inc.'s portfolio?

Top competitors by shared drug class: AdventHealth, Bezmialem Vakif University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sinew-pharma-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Sinew Pharma Inc. — Portfolio Competitive Intelligence Brief

Sinew Pharma Inc. pipeline: 3 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 2 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Panadol®	Panadol®	marketed	Analgesic and antipyretic (non-NSAID)	Cyclooxygenase (COX), primarily in central nervous system	Pain Management
SafeTynadol®	SafeTynadol®	marketed	Analgesic/antipyretic (acetaminophen derivative)	Presumed COX inhibitor and TRPV1 modulator (acetaminophen mechanism)	Pain Management / Fever
Naldebain	Naldebain	marketed			Other

Therapeutic area mix

Other · 1
Pain Management · 1
Pain Management / Fever · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AdventHealth · 1 shared drug class
Bezmialem Vakif University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sinew Pharma Inc.:

Cite this brief

Drug Landscape (2026). Sinew Pharma Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sinew-pharma-inc. Accessed 2026-05-14.